Sign up now for the next quarterly MSOS Member Briefings webinar scheduled to be held on Thursday, December 14, 2017 from 1:00-2:00pm EST. Short medication safety-related presentations for this webinar will include topics on the management of ketamine, elimination of double-checks for SQ insulin, changing systems based on error reports, and update from the FDA on drug shortages and an ISMP update. For more information, click on the header above. To register, go to: https://register.gotowebinar.com/register/5787674558169084418
MSOS News
Post date: 7 years 1 month ago
MSOS is adding a “Quick Survey” feature to our website next month. Members will be asked one new question of interest each month on the MSOS website, that will offer 3 to 5 multiple choice options. Participants will receive instant feedback of the survey results. We are reaching out to MSOS members to ask for ideas/topics for the one question surveys that would be of interest to them. Please submit your ideas as a multiple choice question with answers to admin@medsafetyofficer.org. Members will receive an announcement with each new survey that is posted to the website.
Post date: 7 years 1 month ago
Please note: If you add an attachment to any Forum post, it will not be viewable in the email that is sent to all members. The attachment is only viewable in the Forum section of the MSOS website (www.medsafetyoffice.org).This is due to the functionality of the software we utilize. Please take this into consideration when writing and viewing posts. Thanks.
Post date: 7 years 1 month ago
Med-ERRS, a subsidiary of ISMP, is looking for a few pharmacists who will be attending the ASHP Midyear Clinical Meeting in Orlando FL to participate in a half-day advisory board. The advisory board will be focused on compounding products in the pharmacy. Following the meeting, you may be asked at a later date to review the proceedings, which will be developed into a white paper. The advisory board meeting will take place on Sunday, December 3, 2017 from noon-4PM. There will be an honorarium for participation. If you are interested or have questions, please email Susan Proulx, PharmD at sproulx@med-errs.com, with your resume/CV attached. More details will be provided as we get closer to the meeting. Thanks!
Post date: 7 years 2 months ago
ISMP has introduced a new tool to help hospitals, long-term care facilities, and certain outpatient facilities evaluate their best practices related to high-alert medications, identify opportunities for improvement, and track their experiences over time. The ISMP Medication Safety Self Assessment® for High-Alert Medications focuses on general high-alert medications and 11 specific medication categories--including opioids, insulin, neuromuscular blocking agents, chemotherapy, and moderate and minimal sedation. Participants who submit assessment findings to ISMP anonymously via a secure internet portal by December 15, 2017 will be able to obtain their weighted scores so they can compare themselves to demographically similar organizations. Participation also can help organizations meet requirements for managing high-alert medications from regulatory and accrediting agencies, such as the Centers for Medicare & Medicaid Services and The Joint Commission. To access the self assessment workbook, go to: http://www.ismp.org/selfassessments/SAHAM.